clinical trial · NCT02354222
Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin)
Type 2 Diabetes MellitusCanagliflozinTeneligliptinPlacebo
brief summary
The purpose of this study is to evaluate the efficacy and safety of co-administration of Canagliflozin (TA-7284) and Teneligliptin (MP-513) once daily for 24 weeks in Japanese patients with Type 2 diabetes mellitus who are receiving treatment with Canagliflozin and have inadequate glycemic control.
started
Jan 1, 2015
primary completion
Feb 1, 2016
completion
Feb 1, 2016
last updated
Jan 7, 2026
official title
Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin in Patients With Inadequate Glycemic Control on Canagliflozin)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol